About
Joined V-Bio Ventures in December 2020 as Managing Partner. She spent over 20 years in finance and executive roles across European biotech, including CFO of Merus and CEO of Gadeta.
ContactΒ· self-published, not guessed
Experience
- V-Bio VenturesManaging Partnercurrent2020 β presentGhent, Flemish Region, Belgium
- V-Bio VenturesConsultant2020Ghent, Flemish Region, Belgium
- Tanai TherapeuticsBoard Membercurrent2023 β presentGhent, Flemish Region, Belgium
- AstriVaxBoard Membercurrent2022 β presentLeuven, Flemish Region, Belgium
- AnimabBoard Observer2021 β 2025
- KU LeuvenExternal member of the IOF Council (Industrial Research Fund)2021 β 2024
- OCTIMET Oncology NVBoard Member and CEO2019 β 2024
- Gadeta B.V.Chief Executive Officer2017 β 2019The Randstad, Netherlands
- MerusExecutive Vice President and Chief Operating Officer2016 β 2017
- MerusExecutive Vice President and Chief Financial Officer2010 β 2016
- PanGenetics BVVP Finance2006 β 2010
- Carex S.A.Financial Contoller2004 β 2006Greater Strasbourg Metropolitan Area
- Adprotech LtdFinancial Controller/Company Secretary2001 β 2004Greater Cambridge Area
- P&O FerrymastersManagement Accountant1999 β 2000Ipswich, UK & Mannheim Area, Germany
- Exchem OrganicsAccounts Supervisor1997 β 1999Essex, United Kingdom
- Oddballs International LtdFinancial Controller1994 β 1997Essex, UK
Skills & more
Investor Relations1Lifesciences4Accounting5Biopharmaceuticals3Venture Capital3Biotechnology6Management4Finance7Pharmaceutical Industry1Start-ups1Technology Transfer1Mergers
+2 more
Life SciencesCorporate FinanceFrom Shelley's professional profile.
Colleagues at V-Bio Ventures
Aurelie Nowack
Principal at V-Bio Ventures
Charles Margarit
Associate at V-Bio Ventures
Christina Takke
Managing Partner at V-Bio Ventures
Dennis Pedri
Analyst at V-Bio Ventures
Dr. LoΓ―c Laplanche
Chief Operating Officer at V-Bio Ventures
Dr. Marie-Laurence Gourlay-Chu
Chief Medical Officer at V-Bio Ventures
Katja Rosenkranz
Partner at V-Bio Ventures
Martin Solleveld
Finance Manager at V-Bio Ventures
Frequently asked questions
- Who is Shelley Margetson?
- Joined V-Bio Ventures in December 2020 as Managing Partner. She spent over 20 years in finance and executive roles across European biotech, including CFO of Merus and CEO of Gadeta.
- Where does Shelley Margetson work?
- Shelley Margetson is Managing Partner at V-Bio Ventures.
- Where did Shelley Margetson go to school?
- Shelley Margetson studied at INSEAD (Financial Executive Programme); The Chartered Institute of Management Accountants.
Same school
Also attended INSEAD805
Alexandre ProtCo-founder & CEO of QontoSteve AnaviCo-founder & President of QontoPatrick ClaessenPartner at Cottonwood Technology FundChris BischoffInvestment Team at General CatalystJan HammerInvestor at Index VenturesSandra SchwarzerInvestor at Index Ventures
+ 799 more
Also attended The Chartered Institute of Management Accountants28
Bryan TurnerPartner at Spear CapitalLuke CurranSenior Analyst at Naples Technology VenturesHannah WilliamsonSenior Investment Manager at Edge VCTania HayesCOO, Strategic Equity at Gresham House VenturesNitya AgarwalVice President at 3one4 CapitalLukasz GarbowskiInvestment Director at Btomorrow Ventures
+ 22 more
Shared employers
Also worked at V-Bio Ventures5
Also worked at Tanai Therapeutics2
Also worked at Animab3
Also worked at KU Leuven39
Katrin GeyskensExecutive Director at Capricorn Venture PartnersWouter Van de PutteInvestment Director at Capricorn Venture PartnersKobeFinance Director at Hummingbird VenturesPieter AbbeelAlumni at HouseKatleen VandersmissenManaging Partner at Heran PartnersHerman VerrelstFounding Partner & Senior Advisor at Heran Partners
+ 33 more












.jpg)






.webp)












